glykopyrronium (som glykopyrroniumbromid)/indakaterol (som indakaterolacetat)/mometasonfuroat inh pulv 46 mikrog/aktivering + 114 mikrog/aktivering + 136 mikrog/aktivering
indakaterol/glykopyrronium/mometason inh pulv 114 mikrog/aktivering + 46 mikrog/aktivering + 136 mikrog/aktivering (Helseplattformen)
(sct-id: 1088331000202109)
FK-SNOMED1 (1 FKtekst)
SCT: glykopyrronium (som glykopyrroniumbromid)/indakaterol (som indakaterolacetat)/mometasonfuroat inh pulv 46 mikrog/aktivering + 114 mikrog/aktivering + 136 mikrog/aktivering (sct-id: 1088331000202109)
Glycopyrronium (as glycopyrrolate) 46 microgram and indacaterol (as indacaterol acetate) 114 microgram and mometasone furoate 136 microgram/actuation powder for inhalation in capsule
FEST Virkestofforskrivning:
Indakaterol/Glykopyrronium/Mometason inh pulv, kaps 114 mikrog/46 mikrog/136 mikrog (fest-id: ID_1545B140-3DC0-466C-A5B4-101DCC8DEFD2)
SCT FEST Virkestofforskrivning |
FEST LegemiddelMerkevare |
FK-tekst Rankering |
|---|---|---|
glykopyrronium (som glykopyrroniumbromid)/indakaterol (som indakaterolacetat)/mometasonfuroat inh pulv 46 mikrog/aktivering + 114 mikrog/aktivering + 136 mikrog/aktivering Indakaterol/Glykopyrronium/Mometason inh pulv, kaps 114 mikrog/46 mikrog/136 mikrog |
Enerzair Breezhaler inh pulv, kaps 114 mikrog/46 mikrog/136 mikrog fest-id: ID_473BC38D-2E1A-4CF2-93D3-A3BEF7DF86EB |
Enerzair Breezhaler «Novartis» inhal.pulv. (L, 2) |